Healthcare SaaS Market
Healthcare SaaS market size and growth by segment, the compliance costs that shape pricing, and which buyers hold budget in provider and payer settings.
On this page 8 sections
- What the healthcare SaaS market is actually worth
- Segment by segment: where the growth actually sits
- Who actually holds the budget
- What compliance costs, and what it does to your CAC
- Incumbents and the gaps they leave
- How to market into healthcare without wasting two years
- The honest tradeoffs
- What to do next
- Frequently asked questions
The short answer
The healthcare SaaS market covers cloud software sold to providers, payers, pharma and life sciences, spanning EHR, revenue cycle management, clinical trials, telehealth, patient engagement and payer platforms. Credible estimates put healthcare cloud software between 40 and 70 billion dollars globally in 2026, growing in the high teens annually. Much larger figures quoted as market size usually count total healthcare IT spend, which includes hardware, services and internal staff.
Key points before you start
If you’re building or marketing healthcare software, the first useful thing to know is that almost every market size number you’ll be handed is wrong in the same direction. Vendors, analysts and pitch decks size this market by counting healthcare IT spend, which includes hardware, systems integration, consulting hours and internal staff salaries. The software subscription line inside that total is a fraction of it.
Get the denominator right and the rest of the go to market plan follows: who has budget, how long they take, and what compliance costs before you sell anything.
What the healthcare SaaS market is actually worth
Start with the definition problem. “Healthcare IT market” and “healthcare SaaS market” differ by roughly an order of magnitude depending on whose report you read, and the difference is mostly services.
Analyst estimates from firms including Grand View Research and MarketsandMarkets place healthcare cloud computing in the tens of billions globally, growing in the high teens annually. Narrow that to subscription software sold to healthcare organisations and the credible range for 2026 sits somewhere between 40 and 70 billion dollars worldwide, with North America holding over half.
I’d treat any single figure with suspicion and any figure above 150 billion as an IT spend number wearing a software costume. If your board deck needs a TAM, build it bottom up: number of target organisations, realistic annual contract value, penetration ceiling. That number will be smaller and defensible, which matters more when a sophisticated investor asks how you got there. The general method sits in B2B SaaS market size.
The TAM trap in one example
There are roughly 6,100 hospitals in the United States. If your product sells at 80k a year to hospitals over 200 beds, that is about 2,400 realistic accounts, so a ceiling near 190 million in US hospital ARR. That is a good business. It is not the 100 billion your market report implied, and planning against the wrong one determines how much you raise and how fast you hire.
Segment by segment: where the growth actually sits
The market behaves like six different markets that happen to share a compliance regime.
| Segment | Rough scale | Growth profile | Buying pattern |
|---|---|---|---|
| EHR and clinical systems | Largest segment by revenue | Low single digit, replacement driven | Decade long contracts, near zero churn |
| Revenue cycle management | Large and fragmented | Low to mid teens | ROI led, fastest to close, CFO sponsored |
| Patient engagement and access | Mid sized | Mid to high teens | Departmental entry, expands centrally |
| Telehealth infrastructure | Contracted since 2021 peak | Flat to modest | Increasingly bundled into EHR |
| Clinical trial and site software | Mid sized, high ACV | High teens | Sponsor and CRO budgets, long procurement |
| Payer and claims platforms | Large, highly concentrated | Low to mid teens | Very long cycles, very large contracts |
Two of these deserve emphasis. Revenue cycle management closes fastest because the ROI arithmetic is trivial: denied claims recovered per month against licence cost. Anyone selling clinical workflow improvement is selling a harder story, because the benefit lands as clinician time, and clinician time doesn’t appear as a line a CFO can cut.
Telehealth is the cautionary segment. Enormous 2020 to 2021 growth, then consolidation, then absorption into EHR vendor suites. Standalone telehealth point solutions found the same thing many horizontal categories find: when the incumbent platform ships a passable version, the standalone needs to be very much better, not slightly better.
Editable CSV worksheet
Get the benchmark evaluation worksheet
A worksheet for checking source dates, definitions and sample limitations before you use an industry benchmark.
Who actually holds the budget
Four buyer worlds, and they don’t share procurement processes, budget cycles or vocabulary.
Providers, meaning hospitals, health systems and physician groups. The CIO or CMIO usually owns the decision. Clinical leadership holds veto. The CISO team runs a security review that routinely adds two to three months. The CFO signs above a threshold that varies by system, often 100k. Departmental leads can frequently spend under 25k without central IT approval, which is why land and expand works here when direct enterprise selling stalls.
Payers, meaning insurers and managed care organisations. Fewer targets, much larger contracts, and planning cycles tied to annual benefit years. A payer deal is often 5 to 20 times the size of a comparable provider deal and takes proportionally longer. If you’re building for payers, plan cash for an eighteen month first sale.
Pharma and life sciences. The budget does not sit in IT. It sits in R&D, medical affairs or commercial, which changes everything about who you market to. Veeva built a multi billion dollar company largely by understanding that commercial and R&D budget holders in pharma buy differently from hospital CIOs.
Employers and benefits buyers. Often overlooked, and the entry route for digital health point solutions that can’t get through health system procurement. The buyer is a benefits leader inside a large employer, and the sale looks far more like HR SaaS than like clinical software.
42%
Epic's approximate share of US acute care hospital EHR installations, which makes integration the default strategy for new entrants
KLAS Research
What compliance costs, and what it does to your CAC
Compliance is not a feature. It’s a gate, and it’s priced in before revenue.
HIPAA and a Business Associate Agreement are the minimum to touch protected health information. SOC 2 Type II is effectively mandatory for enterprise health systems. HITRUST CSF certification is increasingly requested by large systems and payers, and it’s the expensive one. Together, expect 120k to 400k in the first year across audit fees, tooling, remediation engineering and the internal time nobody budgets for.
The second cost is cycle length. Security review alone commonly adds 60 to 90 days. Legal negotiation of the BAA adds more. That turns into CAC through sales headcount time, and it’s why healthcare SaaS companies typically run longer payback periods than horizontal peers at the same ACV.
Turn the gate into a marketing surface
Publish a trust page with your certifications, subprocessor list, data residency and a downloadable security overview. Health system security reviewers search for this before your sales team ever speaks to them. It is one of the highest converting non-obvious pages in vertical SaaS, and most vendors bury it three clicks deep in a footer.
Incumbents and the gaps they leave
Epic dominates acute care and, critically for a new entrant, has an integration marketplace rather than an open field. Oracle Health, formerly Cerner, holds the second position with a somewhat different partner posture. For most startups the strategic question isn’t how to displace Epic, it’s how to be the thing that sits on top of Epic and pulls data out of it. Displacement pitches to a system eight years into an Epic rollout lose before the meeting starts.
Veeva owns life sciences CRM and content management with genuine depth, and its vertical dominance is the standard case study for why vertical SaaS commands better retention than horizontal alternatives. Doximity built distribution to physicians directly, which turned into an advertising and hiring business rather than a workflow one. Phreesia occupied patient intake, a workflow that health systems were happy to outsource because it sits at the administrative edge rather than the clinical core.
The pattern in the gaps: incumbents defend the clinical record and the billing engine. They’re much weaker at anything touching the patient before arrival, anything involving unstructured data, and anything that requires shipping monthly rather than annually. That last one is a structural advantage a startup actually keeps.
Newsletter launch list
The Friday SaaS Marketing Brief
Join the list for the upcoming SaaS Marketing Brief. Get the marketing planning worksheet immediately.
How to market into healthcare without wasting two years
A sequence that fits the buying reality
- Pick one buyer world and one segment
Providers, payers, pharma or employers. Committing to two at seed splits a small team across incompatible procurement processes and you will close neither.
- Get the compliance gate done before demand gen
SOC 2 Type II at minimum, HITRUST if you are targeting large systems or payers. You know it worked when security review stops being the reason deals stall.
- Build the trust and integration pages first
Security overview, BAA availability, Epic or Oracle Health integration documentation. These pages get read by evaluators you never meet.
- Lead with a labour cost you remove
Denied claims recovered, prior auth hours saved, documentation minutes per encounter. Quantify it in the unit the CFO already tracks.
- Enter departmentally where you can
Find the sub 25k discretionary budget that avoids central IT. Then prove usage before the enterprise conversation rather than during it.
- Publish clinical evidence, not claims
A single site study with named results beats ten case studies with percentages and no baseline. Healthcare buyers are trained to read methods.
- Plan cash for the cycle you actually have
Model nine to eighteen months for enterprise provider deals. If your runway assumes six, the plan fails on timing rather than on product.
The honest tradeoffs
Healthcare SaaS is slow, expensive to enter, and heavily gated. In exchange you get retention that horizontal software rarely sees, because ripping out a system that clinicians have built workflows around is a project nobody volunteers for.
The failure mode is predictable. Teams underestimate cycle length by half, raise against an inflated TAM, hire a sales team at month nine, and run out of money at month twenty with three pilots and no signed enterprise contract. Pilots in healthcare are not revenue, and treating a paid pilot as proof of a repeatable motion is the most common misreading in the category.
If you’re weighing this vertical against others, SaaS market size by vertical and category compares growth and concentration, horizontal versus vertical SaaS covers the structural trade, and enterprise SaaS market covers the buying committee mechanics that healthcare shares with other regulated categories. For the concentration maths behind Epic’s position, see market share. If you’re still choosing a problem to build against, SaaS software ideas is a better starting point than a market report. The broader picture sits in SaaS market size and growth.
What to do next
Build the bottom up TAM before the next board meeting: count the organisations, set a realistic ACV, apply a penetration ceiling you’d defend under questioning. Then put your compliance timeline next to your runway on the same chart. If the second runs out before the first completes, the marketing plan is not the problem you need to solve this quarter.
Editable CSV worksheet
SaaS Market and Industry Data planning worksheet
A practical market data planning worksheet: decisions, owners, evidence and next actions.
Frequently asked questions
How big is the healthcare SaaS market?
Estimates vary widely by definition. Analyst firms including Grand View Research and MarketsandMarkets put healthcare cloud computing in the tens of billions globally, growing in the high teens per year. The narrower figure, software licence and subscription revenue only, is meaningfully smaller than headline numbers that include IT services, infrastructure and consulting.
Why are healthcare SaaS TAM numbers so inflated?
Because vendors size the market using total healthcare IT spend, which includes hardware, systems integration, internal staff and consulting. A hospital system spending 80 million on IT might spend 12 million on third party software subscriptions. Sizing a business on the 80 million number produces a plan that misses by a factor of six.
What compliance does healthcare SaaS require?
In the US, HIPAA compliance and a signed Business Associate Agreement are the floor. Most enterprise health systems then require SOC 2 Type II, and a growing share require HITRUST CSF certification. In the EU, GDPR plus local health data rules apply. Budget 120k to 400k for the first year of certifications and audits.
Who holds the budget in a hospital software purchase?
Typically the CIO or CMIO owns the decision, with clinical leadership holding veto power and the CFO approving spend above a threshold. Security review sits with the CISO team and can add two to three months on its own. Departmental heads can sometimes buy under 25k without central IT, which is the usual land and expand entry point.
Is healthcare a good vertical for a SaaS startup?
It is a good vertical for patient founders with domain access and a bad one for anyone expecting a twelve month payback. Sales cycles of nine to eighteen months are normal in health systems, and compliance is a fixed cost before the first dollar of revenue. The offsetting benefit is retention, since switching clinical software is genuinely painful.
What are the fastest growing healthcare SaaS segments?
Prior authorisation automation, clinical documentation with ambient AI, patient access and scheduling, and clinical trial site software have all seen strong growth into 2026. The common thread is a measurable labour cost being removed rather than a new capability being added, which is the ROI story health system CFOs accept.
How long is the sales cycle for healthcare SaaS?
Departmental purchases under 25k can close in six to ten weeks. Enterprise health system deals commonly run nine to eighteen months once security review, legal negotiation of the BAA, clinical governance committees and capital budgeting cycles are counted. Payer deals can be longer still and often align to annual planning windows.
The saas-marketing.net editorial team Research and editorial
We research, write and maintain every page on this site. The library explains marketing decisions through practical frameworks, explicit assumptions and references. Corrections can be requested through the contact page.
Published September 11, 2026. Last updated .